Identity
a large, negatively-charged glycosaminoglycan (polysaccharide) composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. Occurs naturally throughout the body, most abundantly in skin, joints, and eyes. In skin, HA is a major component of the extracellular matrix and dermal ground substance, holding water and maintaining tissue turgor. Endogenous HA declines with age. Used topically as sodium hyaluronate (the sodium salt, more stable in cosmetic formulations) in molecular weights ranging from ~10 kDa (very-low, deeply penetrating) through 2,000+ kDa (very-high, surface-forming).
Development & history
- Isolated by Karl Meyer and John Palmer in 1934 from bovine vitreous humor.
- Commercial cosmetic use began in the 1980s.
- Injectable dermal fillers (crosslinked HA) approved in the early 2000s (Restylane 2003, Juvederm 2006).
- Topical multi-molecular-weight formulations emerged in the 2010s and are now standard in premium skincare.
- Today HA is one of the most-used cosmetic ingredients globally, present in serums, creams, sheet masks, and post-procedure products.
Mechanism (as proposed)
a humectant that binds water and holds it near the skin surface. High-molecular-weight HA forms a film on the stratum corneum, reducing transepidermal water loss and giving a smooth, plumped surface. Low-molecular-weight HA can penetrate into the upper epidermis, delivering hydration deeper and — per multi-MW clinical trials — reducing the appearance of fine lines. Very-low-MW HA fragments may signal to skin cells, though this is more relevant in wound-healing contexts than topical cosmetic use. HA is not enzymatically active on collagen or elastin — the appearance benefits come from hydration and surface effects, not from remodeling the extracellular matrix.